Authors

  • Shadieva Khalima Nuridinovna
    Associate Professor of the Department of Propaedeutics of Children's Diseases, Samarkand Medical University, Uzbekistan
  • Qodirova Marxabo Miyassarovna
    Assistant of the Department of Propaedeutics of Children's Diseases, Samarkand Medical University, Uzbekistan

DOI:

https://doi.org/10.37547/ijmscr/Volume04Issue11-03

Keywords:

Dilated hypertrophic restrictive cardiomyopathy

Abstract

The article examines aspects of the clinical course, diagnostics and treatment of various forms of cardiomyopathy (dilated, hypertrophic, restrictive) in children. Due to the relevance of the problem, the obtained data on the features of the clinical course, diagnostics and tactics of patient management are of interest to cardiologists, general practitioners and pediatricians of family clinics.

A total of 37 children aged 0-17 years were examined. Among those examined, the frequency of various forms of cardiomyopathy was: dilated - 62.1%, hypertrophic - 32.4%, restrictive - 5.4%. Anamnestic data, severity of the course, features of ECG, echocardiography, radiography for each form of cardiomyopathy were studied.

Latent, mild, but more often moderate and severe course of the disease was noted. Patients with DCM and HCM often have various rhythm and conduction disorders. Outpatient observation and timely (continuous) therapy of CHF are indicated for children with cardiomyopathies. In severe cases of HCM with obstructive forms of HCM, the issue of surgical treatment is considered.


background image

Volume 04 Issue 11-2024

14


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

11

P

AGES

:

14-22

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

ABSTRACT

The article examines aspects of the clinical course, diagnostics and treatment of various forms of cardiomyopathy

(dilated, hypertrophic, restrictive) in children. Due to the relevance of the problem, the obtained data on the features

of the clinical course, diagnostics and tactics of patient management are of interest to cardiologists, general

practitioners and pediatricians of family clinics.

A total of 37 children aged 0-17 years were examined. Among those examined, the frequency of various forms of

cardiomyopathy was: dilated - 62.1%, hypertrophic - 32.4%, restrictive - 5.4%. Anamnestic data, severity of the course,

features of ECG, echocardiography, radiography for each form of cardiomyopathy were studied.

Latent, mild, but more often moderate and severe course of the disease was noted. Patients with DCM and HCM often

have various rhythm and conduction disorders. Outpatient observation and timely (continuous) therapy of CHF are

indicated for children with cardiomyopathies. In severe cases of HCM with obstructive forms of HCM, the issue of

surgical treatment is considered.

Research Article

CARDIOMYOPATHIES IN CHILDHOOD: CLINICAL COURSE, DIAGNOSIS
AND CARE TACTICS

Submission Date:

October 29, 2024,

Accepted Date:

November 03, 2024,

Published Date:

November 08, 2024

Crossref doi:

https://doi.org/10.37547/ijmscr/Volume04Issue11-03


Shadieva Khalima Nuridinovna

Associate Professor of the Department of Propaedeutics of Children's Diseases, Samarkand Medical University,
Uzbekistan

Qodirova Marxabo Miyassarovna

Assistant of the Department of Propaedeutics of Children's Diseases, Samarkand Medical University,
Uzbekistan






Journal

Website:

https://theusajournals.
com/index.php/ijmscr

Copyright:

Original

content from this work
may be used under the
terms of the creative
commons

attributes

4.0 licence.


background image

Volume 04 Issue 11-2024

15


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

11

P

AGES

:

14-22

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

KEYWORDS

Dilated, hypertrophic, restrictive cardiomyopathy, children, chronic heart failure.

INTRODUCTION

Cardiovascular pathology in childhood is considered a

serious problem due to its prevalence, difficulties in

recognition, features of the course, treatment and

outcomes

[1-9].

Cardiomyopathy

in

pediatric

cardiology

remains

the

least

studied

and,

unfortunately, untreatable heart pathology. High

disability and mortality, non-specificity of clinical and

laboratory markers, lack of effective treatment

methods, difficulties in heart transplantation in

childhood determine the relevance of the problem. In

recent years, an increase in the incidence of various

forms of cardiomyopathy in children has been noted,

and this is primarily due to improved diagnostics. A true

increase in the incidence of cardiomyopathy is also

possible [7, 10-18].

Dilated cardiomyopathy (DCM) is the most common

form of cardiomyopathy in both adults and children.

DCM in children is a primary myocardial disease of

unknown

etiology,

characterized

by

dilation

predominantly of the left ventricle with a decrease in

the contractile ability of the myocardium. Most likely,

DCM has a polyetiological heterogeneous nature,

including viral persistence, genetic determination, and

autoimmune factors [10-16,18,20]. The incidence in

childhood is 0.5%. Genetic forms of DCM account for

approximately 30%. The incidence does not depend on

gender or age. The average age of children at the time

of diagnosis is 6-13 years [11,16,19].

Hypertrophic cardiomyopathy (HCM) is a genetically

determined disease of the heart muscle, characterized

by massive hypertrophy of the myocardium, most

often the left ventricle, with the obligatory

involvement of the interventricular septum. The

population frequency among children is 2.5 per

100,000. According to numerous studies in different

geographical locations around the globe, the

frequency of HCM is 0.2-1.1%. Symptoms of obstruction

are detected in only 20% of individuals with HCM [10-

12,16].

Restrictive cardiomyopathy (RCM) is the least rare of

all cardiomyopathies. The disease is based on

widespread interstitial fibrosis, combined with a sharp

thickening of the endocardium. With this type of

cardiomyopathy, diastolic function of the myocardium

suffers with little change in systolic function. The

etiology of the disease is unknown. It can occur in

children at any age, with a predominance in girls. The

incidence is about 5% among all forms of

cardiomyopathy. The mortality rate in children from


background image

Volume 04 Issue 11-2024

16


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

11

P

AGES

:

14-22

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

the time of diagnosis is 63-75% from 3-6 years,

respectively, from the onset of the disease [10,11,16].

All forms of cardiomyopathy, given the increase in the

frequency of recognition, severity of the disease, lack

of effective methods of therapy, and high mortality,

require further study.

The goalto study the course, diagnostic criteria and

treatment tactics to improve the quality of life and

optimize the prognosis.

METHODS

The study included 37 patients who were inpatients in

the cardiology department and subsequently followed

up as outpatients at the ODMMC from 2019 to 2024.

The observed children were aged 0-17 years, including

19 boys (51.4%) and 18 girls (48.6%). All children

underwent echocardiography, ECG, chest X-ray,

ultrasound of the abdominal organs, and general

clinical tests. The main criteria for their determination

according to echocardiography data (in 4 patients,

additionally, MSCT of the heart and vessels with

contrast) are: the presence of dilation of the cavity or

hypertrophy of the myocardium of the left (in some

cases, the right) ventricle, the predominance of atrial

lesions (in patients with RCM) or ventricles, the degree

of change in the functional state of the heart

(decreased ejection fraction).

RESULTS AND DISCUSSION

When studying the anamnesis, a family history of

cardiomyopathy was found in 8 (21.6%) children, all of

whom had HCM, 2 (5.4%) had intrauterine TORCH

infection, and 12 (33.3%) children were frequently ill. In

our observation, we did not aim to conduct a genetic

examination; according to the anamnesis of our

patients with DCM, no familial cases were identified.

However, according to the literature, about 30-40% of

cases of familial isolated DCM have an established

genetic origin; more than 50 associated genes have

been identified, and this number is constantly

increasing as new genes are discovered [4,11,13,16]. In

all

examined

patients,

the

diagnosis

of

cardiomyopathy was made at least several months

after the onset of the first symptoms, after ineffective

therapy for other diseases (acute and recurrent upper

respiratory tract infections, pneumonia, carditis).

According to the severity of the disease, severe course

was observed in 24 patients (64.9%), moderate course

- 8 (21.6%), mild and asymptomatic - 5 (13.9%). Severe

course was observed mainly in patients with DCM, mild

and asymptomatic - in 5 children with HCM.

Cardiomyopathies in children were accompanied by

circulatory failure of HC I degree (FC1) - 7 (18.9%), HC II

degree (FC2-3) - 20 (54.1%), HC III degree (FC4) - 5

(13.5%). After clinical and instrumental examination, the

following forms of cardiomyopathy were revealed:

DCM - 23 (62.2%), RCM - 2 (5.4%) and HCM - 12 (32.4%),

among the latter, the obstructive form - in 5 children

(13.9%). These data are consistent with the literature on


background image

Volume 04 Issue 11-2024

17


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

11

P

AGES

:

14-22

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

the incidence of various forms of cardiomyopathy

[10,11,15,16]. The distribution by gender was as follows:

among patients with DCM, there were 10 boys (43.5%),

13 girls (56.5%), 8 boys (66.7%) and 4 girls (33.3%) with

HCM, 1 boy (50%) and 1 girl (50%) with RCM.

ECG of patients with DCM reveals signs of left

ventricular hypertrophy (enlargement) (100%), atrial

overload (69.6%), and repolarization disorders, often

of ischemic origin (56.5%). Rhythm disorders include

sinus tachycardia (78.3%), supraventricular tachycardia

(17.4%), pacemaker migration (4.8%), ventricular

extrasystole (39.1%), and polytopic extrasystole in one

patient (4.3%), and atrial flutter (4.3%) (Fig. 1). In ECG in

HCM we found signs of left ventricular hypertrophy

with its overload (100%), repolarization disorders in the

form of ST depression and deep negative T waves (Fig.

2) (58.3%) - a characteristic sign of HCM, bundle branch

block in the form of left anterior block (25%), left

posterior block (8.3%), we found right bundle branch

block in (25%), extrasystoles - in (16.7%). In RCM, signs

of severe right atrium hypertrophy are the most

characteristic sign (100%), in our observations, patients

had rhythm disturbances only in the form of sinus

tachycardia (100%). The frequency of arrhythmias in

children with cardiomyopathy is also shown in the

works of foreign authors [11,13-17]. Arrhythmias are the

most

common

cause

of

sudden

death

in

cardiomyopathy [11,16,19,20].


background image

Volume 04 Issue 11-2024

18


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

11

P

AGES

:

14-22

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

Fig. 1 ECG of patient M. with DCM. Sharp deviation of the EAH to the right, ventricular extrasystoles,

signs of overload of both parts of the heart, changes in the ventricular myocardium, decreased voltage

Fig. 2. ECG of patient A. with RCM. Deviation of the EAH to the right. Signs of severe RA overload.

Imcomplete blockade of the right bundle branch.

According to X-ray data, in DCM the heart is

significantly enlarged in cross-section due to the left or

both ventricles (Fig. 3). CTI was 0.60-0.71. The heart is

of a characteristic spherical or trapezoidal shape. In

(52%) patients, venous congestion was observed. In

HCM the heart shadow is enlarged in cross-section

mainly due to the left ventricle. CTI up to 0.66. In RCM

the pulmonary pattern is not enriched on the X-ray. The

heart shadow is slightly enlarged in cross-section. CTI -

up to 0.60. The arches are smoothed.


background image

Volume 04 Issue 11-2024

19


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

11

P

AGES

:

14-22

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

Fig. 3. X-ray of patient M. with RCM.

In patients with all three forms, regardless of the

severity of the patient's condition, chronic heart failure

of varying degrees was noted. In 3 (25%) patients with

HCM, chronic heart failure was absent during the

survey and examination, in 2 (16.7%) it corresponded to

FC1. All patients with DCM had chronic heart failure.

Upon admission to the hospital FC3-4, upon discharge

- FC2. Patients with RCM were admitted to the hospital

with CHF FC3, and later treated outpatients with CHF

FC2.

In the hospital, children with DCM received cardiotonic

therapy with cardiac glycosides, dopamine if indicated,

ACE inhibitors, beta-blockers (carvedilol), diuretic,

cardiotrophic and symptomatic therapy. Positive

dynamics were noted against the background of the

therapy in the hospital. However, after discharge,

despite

outpatient

treatment,

CHF

gradually

progressed again. 2 (9.1%) girls with DCM died. Their

disease duration was more than 5 years. The remaining

children in the follow-up are under dispensary

registration at the place of residence and receive

symptomatic therapy for CHF. Patients with HCM

received treatment with beta-blockers (egilok) on an

outpatient basis. 1 child was operated on in the cardiac

surgery department of the ODMMC, the condition

after the operation improved significantly, continues

to receive egilok. 2 children with RCM received therapy

for CHF, but without the use of inotropic drugs; they

were treated jointly with a gastroenterologist, since


background image

Volume 04 Issue 11-2024

20


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

11

P

AGES

:

14-22

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

congestion in the liver and ascites led to

gastrointestinal dysfunction. All patients with DCM and

RCM received anticoagulant therapy.

Thus,

the

frequency

of

various

forms

of

cardiomyopathy in children in the overall structure of

cardiovascular diseases is currently increasing.

Diagnostics has improved, and, consequently, the

detection of all forms. Protocols for the treatment of

cardiomyopathy have been developed. Most patients

with severe cardiomyopathy, with proper monitoring

and treatment, have a disease history of more than 5

years. However, a large number of complications

requires that this pathology be classified as a disease

with an unfavorable prognosis.

CONCLUSIONS

1. Among those examined, the frequency of various

forms of cardiomyopathy was: DCM - 61.1%, HCM -

33.3%, RCM - 5.6%.

2. Almost all forms of cardiomyopathy (with the

exception of 3 patients with HCM) were accompanied

by moderate and severe persistent CHF.

3. Often, late detection of the disease in the majority of

patients dictates the need for at least an annual

examination of all children using the echocardiography

method.

4. Most patients with DCM and HCM exhibit various

rhythm and conduction disturbances.

5. Dispensary observation and timely (continuous)

therapy of CHF in children with cardiomyopathy are

indicated.

6. For patients with obstructive forms of HCM, the

issue of surgical treatment is considered.

REFERENCES

1.

Strelyaeva A.V., Gasparyan E.R., Teres I.V., Zuev

S.S., Sagieva A.T., Shadyeva Kh.N., Lazareva N.B.,

Sadykov V.M., Shcheglova T. A. Pecilomycotic

atypical myocarditis in children and features of

their treatment // RKZh. 2011. No. 5. URL:

https://cyberleninka.ru/article/n/petsilomikoznye-

atipichnye-miokardity-u-detey-i-osobennosti-ih-

lecheniya:

2.

Strelyaeva A.V., Shadyeva Kh.N., Lazareva N.B.,

Samylina I.A., Vakhrameeva I.V., Sadykov V.M.,

Mamatkulov Kh.M., Yakovlev A.O., Zuev S. . S. Toxic

cardiopathy and myocarditis of pecilomycosis and

other etiologies in children // RKZh. 2010. No. 3.

URL:

https://cyberleninka.ru/article/n/toksicheskaya-

kardiopatiya-i-miokardity-petsilomikoznoy-i-inoy-

etiologii-u-detey (date of access: 09/08/2024).

3.

Shadieva H. N., Turdieva N.S., Kodirova M. M.

Congenital complete atrioventricular blockade in

children: clinical features and course, approaches

to

treatment

//

Journal

of

hepato-

gastroenterological research. - 2022. - No. SI-3.


background image

Volume 04 Issue 11-2024

21


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

11

P

AGES

:

14-22

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

4.

Shadieva H.N. Hypertrophic cardiomyopathies in

children: a modern view of the problem // Problems

of biology and medicine. - 2020. No. 3. Vol. 119. - P.

214-217.

DOI:

http://doi.org/10.38096/2181-

5674.2020.3.00178

5.

Qodirova MM, Shadiyeva XN Bolalarda norevmatik

miokarditning EKGdagi asosiy simptomlari //

Journal of gastroenterol. research, 2022; 3 (1): 33-

365

6.

Shadieva H.N., Khaidarova S.Kh., Mamutova E.S.

Congenital heart disease: the scale of the problem,

identification of risk factors for the development of

congenital heart disease//J. Gastroenterological

Research, 2021; 3.2(2):67-69 14.

7.

Shadieva H.N., Khaidarova S.Kh., Mamutova E.S.

Clinical

case

of

dilated

cardiomyopathy

complicated by ventricular extrasystole and LV

thrombus. // J. Gastroenterol. Research, 2021;

3.2(2):51-55 15

8.

5.Kodirova M.M., Kholikova G.A.Main Clinical Signs

Of Non-Rheumatic Myocarditis In Children Of

Samarkand Region. //Journal of Medical and

Natural Sciences. Vol 3.No. 2 (2023)

9.

6.Kodirova M.M., Kholikova G.A..Samarqand

xududida bolalarda miokarditning asosiy klinik

simptomlarini uchrashi.Markhabo Miyasarovna

Kodirova, Gulnoz Asatovna Kholikova.Journal of

Hepato-Gastroenterology Research. Vol. 3 No. 2

(2022)

10.

Clinical protocol for diagnosis and treatment of

cardiomyopathy in children//Kazakhstan, 2015: 29

p.

11.

Leontyeva I.V. Problems of modern diagnostics

and treatment of dilated cardiomyopathy in

children. Russian Bulletin of Perinatology and

Pediatrics. 2018;63(2):7-15.

12.

A.T. Shabanova, Haihai Liang, L.V. Yakovleva, T.A.

Yagudin. A modern view of the intracellular

mechanisms of the development of hypertrophic

cardiomyopathy. Pediatrics named after G.N.

Speransky. 2020; 99 (3): 207-211.

13.

Sadykova D.I., Makarova T.P., Sabirova D.R.,

Firsova N.N., Kucheryavaya A.A., Shakurova N.V.,

Khasanova A.R. Familial form of dilated

cardiomyopathy // Russian Bulletin of Perinatology.

and ped., 2021, 66 (5):202-206

14.

Bershova T.V., Basargina E.N., Bakanov M.I., Ivanov

A.P. Dilated cardiomyopathy in children: molecular

and cellular mechanisms of dysfunction.//

Pediatrics named after G.N. Speransky. 2013; 92 (5).

15.

Lipshultz SE, Cochran TR, Briston DA, Brown SR,

Sambatakos PJ, Miller TL et al. Pediatric

cardiomyopathies: causes, epidemiology, clinical

course, preventive strategies and therapies. Future

Cardiol 2013; 9: 817-848.

16.

Hong YM. Cardiomyopathies in children. Korean J

Pediatr.

2013

Feb;56(2):52-9.

doi:

10.3345/kjp.2013.56.2.52. Epub 2013 Feb 25. PMID:

23482511; PMCID: PMC3589591.


background image

Volume 04 Issue 11-2024

22


International Journal of Medical Sciences And Clinical Research
(ISSN

2771-2265)

VOLUME

04

ISSUE

11

P

AGES

:

14-22

OCLC

1121105677
















































Publisher:

Oscar Publishing Services

Servi

17.

Alexander PM, Daubeney PE, Nugent AW, Lee KJ,

Turner C, Colan SD et al. Long-term outcomes of

dilated

cardiomyopathy

diagnosed

during

childhood: results from a national population-

based study of childhood cardiomyopathy.

Circulation 2013; 128:2039-2046.

18.

Latus H., Gummel K., Klinge K., Moysich A., Khalil

M., Mazhari N. et al. Focal myocardial fibrosis

assessed by late gadolinium enhancement

cardiovascular magnetic resonance in children and

adolescents with dilated cardiomyopathy. J

Cardiovasc Magn Reson 2015; 17:34.

19.

Halliday BP, Cleland JG, Goldberger JJ, Prasad SK

Personalizing Risk Stratification for Sudden Death

in Dilated Cardiomyopathy: The Past, Present, and

Future. Circulation 2017; 136(2): 215-231.

20.

Reddy S, Fung A, Manlhiot C, Tierney ES, Chung

WK, Blume E, Kaufman BD et al. Adrenergic

receptor geno-type influences heart failure

severity and β

-blocker response in children with

dilated cardiomyopathy. Pediatr Res 2015; 77(2):

363-369.

References

Strelyaeva A.V., Gasparyan E.R., Teres I.V., Zuev S.S., Sagieva A.T., Shadyeva Kh.N., Lazareva N.B., Sadykov V.M., Shcheglova T. A. Pecilomycotic atypical myocarditis in children and features of their treatment // RKZh. 2011. No. 5. URL: https://cyberleninka.ru/article/n/petsilomikoznye-atipichnye-miokardity-u-detey-i-osobennosti-ih-lecheniya:

Strelyaeva A.V., Shadyeva Kh.N., Lazareva N.B., Samylina I.A., Vakhrameeva I.V., Sadykov V.M., Mamatkulov Kh.M., Yakovlev A.O., Zuev S. . S. Toxic cardiopathy and myocarditis of pecilomycosis and other etiologies in children // RKZh. 2010. No. 3. URL: https://cyberleninka.ru/article/n/toksicheskaya-kardiopatiya-i-miokardity-petsilomikoznoy-i-inoy-etiologii-u-detey (date of access: 09/08/2024).

Shadieva H. N., Turdieva N.S., Kodirova M. M. Congenital complete atrioventricular blockade in children: clinical features and course, approaches to treatment // Journal of hepato-gastroenterological research. - 2022. - No. SI-3.

Shadieva H.N. Hypertrophic cardiomyopathies in children: a modern view of the problem // Problems of biology and medicine. - 2020. No. 3. Vol. 119. - P. 214-217. DOI: http://doi.org/10.38096/2181-5674.2020.3.00178

Qodirova MM, Shadiyeva XN Bolalarda norevmatik miokarditning EKGdagi asosiy simptomlari // Journal of gastroenterol. research, 2022; 3 (1): 33-365

Shadieva H.N., Khaidarova S.Kh., Mamutova E.S. Congenital heart disease: the scale of the problem, identification of risk factors for the development of congenital heart disease//J. Gastroenterological Research, 2021; 3.2(2):67-69 14.

Shadieva H.N., Khaidarova S.Kh., Mamutova E.S. Clinical case of dilated cardiomyopathy complicated by ventricular extrasystole and LV thrombus. // J. Gastroenterol. Research, 2021; 3.2(2):51-55 15

Kodirova M.M., Kholikova G.A.Main Clinical Signs Of Non-Rheumatic Myocarditis In Children Of Samarkand Region. //Journal of Medical and Natural Sciences. Vol 3.No. 2 (2023)

Kodirova M.M., Kholikova G.A..Samarqand xududida bolalarda miokarditning asosiy klinik simptomlarini uchrashi.Markhabo Miyasarovna Kodirova, Gulnoz Asatovna Kholikova.Journal of Hepato-Gastroenterology Research. Vol. 3 No. 2 (2022)

Clinical protocol for diagnosis and treatment of cardiomyopathy in children//Kazakhstan, 2015: 29 p.

Leontyeva I.V. Problems of modern diagnostics and treatment of dilated cardiomyopathy in children. Russian Bulletin of Perinatology and Pediatrics. 2018;63(2):7-15.

A.T. Shabanova, Haihai Liang, L.V. Yakovleva, T.A. Yagudin. A modern view of the intracellular mechanisms of the development of hypertrophic cardiomyopathy. Pediatrics named after G.N. Speransky. 2020; 99 (3): 207-211.

Sadykova D.I., Makarova T.P., Sabirova D.R., Firsova N.N., Kucheryavaya A.A., Shakurova N.V., Khasanova A.R. Familial form of dilated cardiomyopathy // Russian Bulletin of Perinatology. and ped., 2021, 66 (5):202-206

Bershova T.V., Basargina E.N., Bakanov M.I., Ivanov A.P. Dilated cardiomyopathy in children: molecular and cellular mechanisms of dysfunction.// Pediatrics named after G.N. Speransky. 2013; 92 (5).

Lipshultz SE, Cochran TR, Briston DA, Brown SR, Sambatakos PJ, Miller TL et al. Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies. Future Cardiol 2013; 9: 817-848.

Hong YM. Cardiomyopathies in children. Korean J Pediatr. 2013 Feb;56(2):52-9. doi: 10.3345/kjp.2013.56.2.52. Epub 2013 Feb 25. PMID: 23482511; PMCID: PMC3589591.

Alexander PM, Daubeney PE, Nugent AW, Lee KJ, Turner C, Colan SD et al. Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy. Circulation 2013; 128:2039-2046.

Latus H., Gummel K., Klinge K., Moysich A., Khalil M., Mazhari N. et al. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy. J Cardiovasc Magn Reson 2015; 17:34.

Halliday BP, Cleland JG, Goldberger JJ, Prasad SK Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future. Circulation 2017; 136(2): 215-231.

Reddy S, Fung A, Manlhiot C, Tierney ES, Chung WK, Blume E, Kaufman BD et al. Adrenergic receptor geno-type influences heart failure severity and β-blocker response in children with dilated cardiomyopathy. Pediatr Res 2015; 77(2): 363-369.